Survival associated with chemotherapy and prognostic biomarkers in penile cancer at a reference hospital in the Northeast Brazil from 2000 to 2021. This is an ASCO Meeting Abstract from the 2024 ASCO ...

It’s every man’s worst nightmare. Penis cancer cases are rising around the world and are expected to surge a staggering 77% in the next 26 years, according to an alarming new investigation by BBC. The ...

Penile and urethral cancers are rare but treatable if detected early. Know the subtle warning signs, risk factors, and why ...

Patients with locally advanced penile squamous cell carcinoma who responded to neoadjuvant chemotherapy followed by consolidative lymphadenectomy experienced improved long-term survival outcomes.

Penile cancer is a rare malignancy, but one with uniquely profound consequences for sexual health, body image, and intimate relationships. While advances in surgical management have improved ...

SAN FRANCISCO -- A combination of cemiplimab (Libtayo) and standard-of-care chemotherapy appeared to be effective in patients with locally advanced or metastatic penile cancer, according to findings ...

Please provide your email address to receive an email when new articles are posted on . Patients who responded to treatment had a significant median OS benefit compared with non-responders. Over ...

Between 1999 and 2020, there were 5833 patients who died from penile cancer in the US. The United States has seen an increase in penile cancer deaths in recent years, according to data published in ...

Keytruda plus platinum-based chemotherapy appeared to be safe and effective in treating penile squamous cell carcinoma. Keytruda (pembrolizumab) plus platinum-based chemotherapy was both safe and ...

In a phase 2 trial of patients with advanced penile cancer mostly refractory to platinum-based chemotherapy, avelumab treatment produced objective response in a few, but did not prolong survival ...

A 68-year-old man presented to the emergency department with haematuria and penile pain. His medical history included benign prostatic hyperplasia, but no follow-up examinations had been performed.